Published

The Potential of Psychedelics for End of Life and Palliative Care.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Current topics in behavioral neurosciences
Date: 2022-01-01
Source: PubMed
DOI: 10.1007/7854_2021_278
PubMed: 34958455

Authors

Yaden DB Nayak SM Gukasyan N Anderson BT Griffiths RR

Watch author

Derived topics and classifications

psilocybin Depression End-of-Life Distress Wellbeing Review Article Healthcare Workers Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psilocybin-containing mushroom-assisted psychotherapy is associated with sustained psychological and somatic improvements: two case studies from JamaicaFrontiers in Psychiatry · 2026-07-29 Lysergic Acid Diethylamide (LSD) in Palliative Care: a Randomised, Double-blind, Active-placebo Controlled Phase II Study (LPC-Study)ClinicalTrials.gov · 2026-04-29 Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping reviewJournal of Psychedelic Studies · 2026-03-09 The Safety, Feasibility, and Acceptability of Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain (P-PC)ClinicalTrials.gov · 2025-07-23 An Open-Label Investigation of the Effects of Sub-Perceptual Repeat Dosing of Psilocybin on the Behavioural and Cognitive Symptoms of Fragile X Syndrome in Adult PatientsClinicalTrials.gov · 2024-05-08 An Open Label Pragmatic Feasibility Study on a Resilience Focused Community of Practice Program With Psilocybin-assisted Therapy (PaT) for End-of-Life Patients.ClinicalTrials.gov · 2023-07-25 The Potential Role of Serotonergic Hallucinogens in Depression Treatment.Life (Basel, Switzerland) · 2021-07-29 Psilocin fosters neuroplasticity in iPSC-derived human cortical neuronseLife · 2026-03-27